Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAGRASIB vs ADALIMUMAB-ATTO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADAGRASIB vs ADALIMUMAB-ATTO: Safety Overview

Metric ADAGRASIB ADALIMUMAB-ATTO
Total FAERS Reports 899 1,146
Deaths Reported 315 7
Death Rate 35.0% 0.6%
Hospitalizations 350 68
Average Patient Age 68.3 yrs 53.7 yrs
% Female Patients 56.4% 73.2%
FDA Approval Date Dec 12, 2022 N/A
Manufacturer Mirati Therapeutics, Inc N/A
Route ORAL N/A
Marketing Status Prescription Prescription